4 January 2024 in Lab on a Chip
This review outlines Chimeric antigen receptor (CAR)-T cell manufacturing, highlights challenges, and explores successful microfluidic approaches and related technologies to address them.
28 July 2023 in Nano Letters
7 March 2025 in Advanced Science
Chimeric antigen receptor (CAR)‐T cell therapy has revolutionized cancer treatment, yet challenges such as manufacturing complexity, high costs, and safety concerns have spurred the development of alternatives like CAR‐natural killer (NK) cell immunotherapies. CAR‐NK cell therapies provide innate cytotoxicity with antigen‐independent targeting, reducing safety risks while improving therapeutic efficacy. However, efficient genomic engineering and large‐scale production of allogeneic NK cells remain significant obstacles. To address these challenges, a novel microfluidic gene delivery platform is developed, the Y‐hydroporator, designed for allogeneic NK cell immunotherapy. This platform features a Y‐shaped microchannel where NK cells experience rapid hydrodynamic stretching near the stagnation point, creating transient membrane discontinuities that facilitate the uptake of exogenous cargo. The Y‐hydroporator achieves high delivery and transfection efficiency, processing ≈2 × 10 6 cells min −1 while maintaining long‐term cell viability (>89%) and functionality. Using this platform, human primary CAR‐NK cells and NKG2A‐knockout NK cells are successfully generated by delivering anti‐CD19 CAR mRNA and CRISPR/Cas9 ribonucleoproteins, respectively. These engineered NK cells demonstrated enhanced cytotoxicity, underscoring the potential of the Y‐hydroporator as a transformative tool for advancing allogeneic NK cell‐based immunotherapies.
26 February 2026 in bioRxiv
Stem cell aging significantly impairs therapeutic efficacy, requiring innovative strategies to restore potency. We present a microfluidic cell-compressing platform for reactivation (μ-CPR) designed to apply controlled hydrodynamic deformation to late-passage stem cells. This mechanical stimulation facilitates functional reactivation without external chemical cues. Within a defined window, μ-CPR effectively reduces oxidative stress, SA-β-Gal activity, and γH2AX foci, while simultaneously restoring proliferation and canonical stemness markers (OCT4, SOX2, and KLF4). Mechanical stimulation via μ-CPR induces coordinated structural remodeling: nuclei become more compact, actin cortex organization is restored, α-actinin redistributes to focal adhesions, and microtubule networks are restructured, suggesting a rebalanced intracellular tension. Transcriptomic and proteomic analyses reveal that this process reprograms extracellular matrix remodeling and DNA repair pathways while attenuating pro-fibrotic and senescence-associated secretory phenotype (SASP)-associated pathways. Crucially, this reactivation occurs without compromising fundamental MSC hallmarks, preserving intrinsic immunophenotypes and multilineage differentiation potential. Functionally, μ-CPR-processed stem cells demonstrate restored in vitro wound closure and enhanced tissue repair in vivo , with efficacy appearing dependent on mechanical dosage. This platform establishes a non-genetic, mechanobiological approach to restoring stem cell function, offering a scalable strategy for functional reactivation and potentially paving the way toward comprehensive cellular rejuvenation.
9 September 2026 in Small